Literature DB >> 7668901

Clinical implications of IgA rheumatoid factor subclasses.

T Jónsson1, H Thorsteinsson, S Arinbjarnarson, J Thorsteinsson, H Valdimarsson.   

Abstract

OBJECTIVES: To evaluate the diagnostic and pathogenetic significance of IgA rheumatoid factor (RF) subclasses in rheumatoid arthritis (RA).
METHODS: Rheumatoid factors of the IgA class and IgA1 and IgA2 subclasses were measured by enzyme linked immunosorbent assay in 58 patients with RA, 31 patients with other rheumatic diseases, 30 non-rheumatic individuals with increased concentrations of IgA RF, and in 100 randomly selected healthy controls.
RESULTS: Using a 95% cut off for the controls, 55% of the RA patients had increased total IgA RF, 64% IgA1 RF, and 60% IgA2 RF. RA patients with extraarticular manifestations more often had increased concentrations of IgA RF and both subclasses than patients without such manifestations (p < or = 0.01). Nearly all (31/32) RA patients with increased IgA RF had increases in both IgA RF subclasses, compared with 67% (20/30 of nonrheumatic symptom free individuals with increased IgA RF (p = 0.002).
CONCLUSION: Increased concentrations of the IgA2 RF subclass appears to be more specific for RA than increased IgA1 RF. Measurement of IgA RF subclasses may be clinically useful.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7668901      PMCID: PMC1009938          DOI: 10.1136/ard.54.7.578

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

1.  Estimates of the prevalence of rheumatic diseases in the population of Tecumseh, Michigan, 1959-60.

Authors:  W M Mikkelsen; H J Dodge; I F Duff; H Kato
Journal:  J Chronic Dis       Date:  1967-06

Review 2.  Is measurement of rheumatoid factor isotypes clinically useful?

Authors:  T Jónsson; H Valdimarsson
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

3.  The role of the laboratory in rheumatology. Rheumatoid factors.

Authors:  T Egeland; E Munthe
Journal:  Clin Rheum Dis       Date:  1983-04

4.  Radioimmunoassay of IgG and IgM rheumatoid factors reacting with human IgG.

Authors:  D A Carson; S Lawrance; M A Catalano; J H Vaughan; G Abraham
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

5.  Use of monoclonal antibodies and F(ab')2 enzyme conjugates in ELISA for IgM, IgA and IgG rheumatoid factors.

Authors:  I Teitsson; H Valdimarsson
Journal:  J Immunol Methods       Date:  1984-07-06       Impact factor: 2.303

6.  Enzyme-linked immunosorbent assay (ELISA) screening test for detection of rheumatoid factor.

Authors:  T Jonsson; J A Arnason; H Valdimarsson
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

7.  IgA rheumatoid factor in the sera and saliva of patients with rheumatoid arthritis and Sjögren's syndrome.

Authors:  J V Dunne; D A Carson; H L Spiegelberg; M A Alspaugh; J H Vaughan
Journal:  Ann Rheum Dis       Date:  1979-04       Impact factor: 19.103

8.  Isotype-specific measurement of rheumatoid factor with reference to clinical features of rheumatoid arthritis.

Authors:  A Tarkowski; L A Nilsson
Journal:  J Clin Lab Immunol       Date:  1983-11

9.  Prospective study of early rheumatoid arthritis. I. Prognostic value of IgA rheumatoid factor.

Authors:  I Teitsson; R H Withrington; M H Seifert; H Valdimarsson
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

10.  Rheumatoid factors in rheumatoid arthritis and vasculitis.

Authors:  M L Westedt; P Herbrink; J L Molenaar; E de Vries; P Verlaan; T Stijnen; A Cats; J Lindeman
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

View more
  3 in total

Review 1.  Progress in the use of biochemical and biological markers for evaluation of rheumatoid arthritis.

Authors:  R M Nakamura
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Cigarette smoking, disease severity and autoantibody expression in African Americans with recent-onset rheumatoid arthritis.

Authors:  T R Mikuls; L B Hughes; A O Westfall; V M Holers; L Parrish; D van der Heijde; M van Everdingen; G S Alarcón; D L Conn; B Jonas; L F Callahan; E A Smith; G Gilkeson; G Howard; L W Moreland; S L Bridges
Journal:  Ann Rheum Dis       Date:  2008-01-15       Impact factor: 19.103

Review 3.  Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?

Authors:  Kevin Didier; Loïs Bolko; Delphine Giusti; Segolene Toquet; Ailsa Robbins; Frank Antonicelli; Amelie Servettaz
Journal:  Front Immunol       Date:  2018-03-26       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.